APOE and Alzheimer disease: In contrast to ROSMAP, there was limited differential expression between the dementia and non-dementia groups in the APOE4 analysis, with only 18 DEGs compared to 152 based on AD pathology status (only 12 APOE4 carriers in the non-dementia group).